An overview of chemotherapeutic targets for antimalarial drug discovery

Pharmacology and Therapeutics

Volumn 81, Issue 2, 1999, Pages 91-110

  Olliaro, Piero L ^a   Yuthavong, Yongyuth ^b  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b NATIONAL SCIENCE AND TECHNOLOGY DEVELOPMENT AGENCY   (Thailand)

Author keywords

Chemotherapy; Drug discovery; Malaria; Targets

Indexed keywords

ANTIMALARIAL AGENT; ENZYME; FREE RADICAL; NEW DRUG;

DIGESTIVE SYSTEM; DRUG DESIGN; DRUG RESISTANCE; DRUG SCREENING; DRUG TARGETING; MALARIA; OXIDATION REDUCTION REACTION; PLASMODIUM; PRIORITY JOURNAL; REVIEW;

ANTIMALARIALS; ERYTHROCYTE MEMBRANE; GLYCOLYSIS; HEMOGLOBINS; HUMANS; MALARIA; NUCLEIC ACIDS; SIGNAL TRANSDUCTION; TECHNOLOGY, PHARMACEUTICAL;

EID: 0033004991     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-7258(98)00036-9     Document Type: Review

References (208)

1. Aikawa M. Variations in structure and function during the life cycle of malarial parasites. Bull. WHO. 55:1978;139-156.
2. Anonymous Can herbicides destroy parasites? Science. 275:1997;1393.
3. Asawamahasakda V., Yuthavong Y. The methionine synthesis cycle and salvage of methyltetrahydrofolate from host red cells in the malaria parasite (Plasmodium falciparum). Parasitology. 107:1993;1-10.
4. Atamna H., Pascarmona G., Ginsburg H. Hexose-monophosphate shunt activity in intact Plasmodium falciparum-infected erythrocytes and in free parasites. Mol. Biochem. Parasitol. 67:1994;79-89.
5. Barker R.H. Jr., Metelev V., Rapaport E., Zamecnik P. Inhibition of Plasmodium falciparum malaria using antisense oligonucleotides. Proc. Natl. Acad. Sci. USA. 93:1996;514-518.
6. Basco L.K., Eldin de Pecoulas P., Wilson C.M., Le Bras J., Mazabraud A. Point mutations in the dihydrofolate reductase-thymidylate synthase gene and pyrimethamine and cycloguanil resistance in Plasmodium falciparum. Mol. Biochem. Parasitol. 69:1995;135-138.
7. Basilico N., Monti D., Olliaro P., Taramelli D. Non-iron porphyrins inhibit beta-haematin (malaria pigment) polymerisation. FEBS Lett. 409:1997;297-299.
8. Becker K., Müller S., Keese M.A., Walter R.D., Schirmer R.H. A glutathione reductase-like flavoenzyme of the malaria parasite Plasmodium falciparum. structural considerations based on the DNA sequence Biochem. Soc. Trans. 24:1996;67-72.
9. Becuwe P., Gratepunche S., Fourmaux M.N., Van Beeumen J., Samyn B., Mercuro-Puijalon O., Touzel J.P., Slomianny C., Camus D., Dive D. Characterization of iron-dependent endogenous superoxide dismutase of Plasmodium falciparum. Mol. Biochem. Parasitol. 76:1996;125-134.
10. Bitonti A.J., Sioerdsma A., Mc Cann P.P., Kyle D.E., Oduola A.M.J., Rossan R.N., Milhous W.K., Davidson D.E. Reversal of chloroquine resistance in malaria parasite Plasmodium falciparum by desipramine. Science. 242:1988;1301-1303.
11. Bitonti A.J., Dumont J.A., Bush T. Bis(benzyl)polyamine analogs inhibit the growth of chloroquine-resistant human malaria parasites (Plasmodium falciparum) in vitro and in combination with alpha-difluoromethylornithine cure murine malaria. Proc. Natl. Acad. Sci. USA. 86:1989;651-655.
12. Blauer G., Akkawi M. Investigations of B- and beta-hematin. J. Inorg. Biochem. 66:1997;145-152.
13. Bodammer J.E., Bahr G.F. The initiation of a "metabolic window" in the surface of host erythrocytes by Plasmodium berghei NYU-2. Lab. Invest. 28:1973;708-718.
14. Bohle D.S., Helms J.B. Synthesis of beta-hematin by dehydrohalogenation of hemin. Biochem. Biophys. Res. Commun. 193:1993;504-508.
15. Bohle D.S., Dinnebier R.E., Madsen S.K., Stephens P.W. Characterization of the products of the heme detoxification pathway in malarial late trophozoites by X-ray diffraction. J. Biol. Chem. 272:1997;713-716.
16. Bolhuis H., van Veen H.W., Poolman B., Driessen A.J., Konings W.N. Mechanisms of multidrug transporters. FEMS Microbiol. Rev. 21:1997;55-84.
17. Bray P.G., Howells R.E., Ritchie G.Y., Ward S.A. Rapid chloroquine efflux phenotype in both chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum. Biochem. Pharmacol. 44:1992;1317-1324.
18. Brobey R.K., Sano G., Itoh F., Aso K., Kimura M., Mitamura T., Horii T. Recombinant Plasmodium falciparum dihydrofolate reductase-based in vitro screen for antifolate antimalarials. Mol. Biochem. Parasitol. 81:1996;225-237.
19. Budimulja, A. S., Syafruddin, Tapchaisri, P., Wilairat, P. and Marzuki, S. (1997) The sensitivity of Plasmodium protein synthesis to prokaryotic ribosomal inhibitors. Mol. Biochem. Parasitol. 84: 137-141.
20. Butcher G.A. Antimalarial drugs and the mosquito transmission of Plasmodium. Int. J. Parasitol. 27:1997;975-987.
21. Bzik D.J., Fox B.A., Gonyer K. Expression of Plasmodium falciparum lactate dehydrogenase in Escherichia coli. Mol. Biochem. Parasitol. 59:1993;155-166.
22. Cabantchik Z.I., Glickstein H., Golenser L., Loyevsky M., Tsafack A. Iron chelators. mode of action as antimalarials Acta Haematol. 95:1996;70-77.
23. Carreras C.W., Santi D.V. The catalytic mechanism and structure of thymidilate synthase. Annu. Rev. Biochem. 64:1995;761-762.
24. Chakrabarti D., Schuster S.M., Chakrabarti R. Cloning and characterization of subunit genes of ribonucleotide reductase, a cell-cycle-regulated enzyme, from Plasmodium falciparum. Proc. Natl. Acad. Sci. USA. 90:1993;12020-12024.
25. Chou A.C., Fitch C.D. Control of heme polymerase by chloroquine and other quinoline derivatives. Biochem. Biophys. Res. Commun. 195:1992;422-427.
26. Chou A.C., Chevli R., Fitch C.D. Ferriprotoporphyrin IX fulfils the criteria for identification as the chloroquine receptor of malaria parasites. Biochemistry. 19:1980;1543-1549.
27. Clough B., Strath M., Preiser P., Denny P., Wilson I. Thiostrepton binds to malarial plastid rRNA. FEBS Lett. 406:1997;123-125.
28. Cowman A.F., Morry M.J., Biggs B.A., Cross G.A., Foote S.J. Amino acid changes linked to pyrimethamine resistance in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum. Proc. Natl. Acad. Sci. USA. 85:1988;9109-9113.
29. Cowman A.F., Karcz S., Galatis D., Culvenor J.C. A P-glycoprotein homologue of Plasmodium falciparum is located on the digestive vacuole. J. Cell Biol. 113:1991;1033-1042.
30. Cumming J.N., Ploypradith P., Posner G. Antimalarial activity of artemisinin (Qinghaosu) and related trioxanes. mechanism(s) of action Adv. Pharmacol. 37:1996;253-297.
31. Dame J.B., Reddy G.R., Yowell C.A., Dunn B.M., Kay J., Berry C. Sequence, expression and modeled structure of an aspartic proteinase from the human malaria parasite Plasmodium falciparum. Mol. Biochem. Parasitol. 64:1994;177-190.
32. Dawson P.A., Cochran D.A.E., Emmerson B.T., Gordon R.B. Inhibition of Plasmodium falciparum hypoxanthine-guanine phosphoribosyltransferase mRNA by antisense oligodeoxynucleotide sequence. Mol. Biochem. Parasitol. 60:1993;153-156.
33. Desai S.A., Rosenberg R.L. Pore size of the malaria parasite's nutrient channel. Proc. Natl. Acad. Sci. USA. 94:1997;2045-2049.
34. Desai S.A., Krogstad D.J., McCleskey E.W. A nutrient-permeable channel on the intraerythrocytic malaria parasite. Nature. 362:1994;643-646.
35. Desjardins R.E., Canfield C.J., Haynes J.D., Chulay J.D. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob. Agents Chemother. 16:1979;710-718.
36. Divo A.A., Sartorelli A.C., Patton C.L., Bia F.J. Activity of fluoroquinolone antibiotics against Plasmodium falciparum in vitro. Antimicrob. Agents Chemother. 32:1988;1182-1186.
37. Doerig C.D. Signal transduction in malaria parasites. Parasitol. Today. 13:1997;307-313.
38. Dominguez J.N., Lopez S., Charris J., Iarruso L., Lobo G., Semenov A., Olson J.E., Rosenthal P.J. Synthesis and antimalarial effects of phenothiazine inhibitors of a Plasmodium falciparum cysteine protease. J. Med. Chem. 40:1997;2726-2732.
39. Dorn A., Stoffel R., Matile H., Bubendorf A., Ridley R. Malarial haemozoin/beta-haematin supports haem polymerization in the absence of protein. Nature. 374:1995;269-271.
40. Dunn C.R., Banfield M.J., Barker J.J., Higham C.W., Moreton K.M., Turgut-Balik D., Brady R.L., Holbrook J.J. The structure of lactate dehydrogenase from Plasmodium falciparum reveals a new target for anti-malarial design. Nature Struct. Biol. 3:1996;912-915.
41. Eakin A.E., Guerra A., Focia P.J., Torres-Martinez J., Craig S.P. III Hypohanthine phosphoribosyltransferase from Trypanosoma cruzi as a target for structure-based inhibitor design. crystallization and inhibition studies with purine analogues Antimicrob. Agents Chemother. 41:1997;1686-1689.
42. Egan T.J., Ross D.C., Adams P.A. Quinoline anti-malarial drugs inhibit spontaneous formation of beta-haematin (malaria pigment). FEBS Lett. 352:1994;54-57.
43. Egan T.J., Ross D.C., Adams P.A. The mechanism of action of quinolines and related anti-malarial drugs. S. Afr. J. Sci. 92:1996;11-14.
44. El Abbadi N., Ancelin M.L., Vial H.J. Use of radioactive ethanolamine incorporation into phospholipids to assess in vitro antimalarial activity by the semiautomated microdilution technique. Antimicrob. Agents Chemother. 36:1992;50-55.
45. El Abbadi N., Ancelin M.L., Vial H.J. Phospholipid metabolism of serine in Plasmodium-infected erythrocytes involves phosphatidylserine and direct serine decarboxylation. Biochem. J. 324:1997;435-445.
46. Elmendorf H.G., Haldar K. Secretory transport in Plasmodium. Parasitol. Today. 9:1993;98-102.
47. Fairfield A.S., Meshnick S.R., Eaton J.W. Malaria parasites adopt host cell superoxide dismutase. Science. 221:1983;764-766.
48. Fairfield A.S., Abosh A., Rama A., Eaton J.W., Meshnick S.R. Oxidant defence enzymes of P. falciparum. Mol. Biochem. Parasitol. 30:1988;77-82.
49. Farber P.M., Becker K., Muller S., Schirmer R.H., Franklin R.M. Molecular cloning and characterization of a putative glutathione reductase gene, the PfGR2 gene, from Plasmodium falciparum. Eur. J. Biochem. 239:1996;655-661.
50. Farber P.M., Graeser R., Franklin R.M., Kappes B. Molecular cloning and characterization of a second calcium-dependent protein kinase of Plasmodium falciparum. Mol. Biochem. Parasitol. 87:1997;211-216.
51. Feagin J.E. The 6-kb element of Plasmodium falciparum encodes mitochondrial cytochrome genes. Mol. Biochem. Parasitol. 52:1992;145-148.
52. Feagin J.E. The extrachromosomal DNAs of apicomplexan parasites. Annu. Rev. Microbiol. 48:1994;81-104.
53. Feagin J.E., Drew M.E. Plasmodium falciparum. alterations in organelle transcript abundance during the erythrocytic cycle Exp. Parasitol. 80:1995;430-440.
54. Feagin J.E., Mericle B.L., Werner E., Morris M. Identification of additional rRNA fragments encoded by the Plasmodium falciparum 6 kb element. Nucl. Acids Res. 25:1997;438-446.
55. Foote S.J., Cowman A.F. The mode of action and the mechanism of resistance to antimalarial drugs. Acta Trop. 56:1994;157-171.
56. Foote S.J., Galatis D., Cowman A.F. Amino acids in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum involved in cycloguanil resistance differ from those involved in pyrimethamine resistance. Proc. Natl. Acad. Sci. USA. 87:1990;3014-3017.
57. Francis S.E., Gluzman I.Y., Oksman A., Knickerbocker A., Mueller R., Bryant M.L., Sherman D.R., Russel D.G., Goldberg D.E. Molecular characterization and inhibition of a Plasmodium falciparum aspartic hemoglobinase. EMBO J. 13:1994;306-317.
58. Francis S.E., Banerjee R., Goldberg D.E. Biosynthesis and maturation of the malaria aspartic hemoglobinases plasmepsins I and II. J. Biol. Chem. 272:1997;14961-14968.
59. Fry M., Pudney M. Site of action of the antimalarial hydroxynaphthoquinone, 2-[trans-4-(4′-chlorophenyl) cyclohexyl]-3-hydroxy-1,4-naphthoquinone (566C80). Biochem. Pharmacol. 43:1992;1545-1553.
60. Fry M., Webb E., Pudney M. Effect of mitochondrial inhibitors on adenosine triphosphate levels in Plasmodium falciparum. Comp. Biochem. Physiol. B. 96:1990;775-782.
61. Gamage S.A., Tepsiri N., Wilairat P., Woljcik S.J., Figgitt D.P., Ralph R.K., Denny W.A. Synthesis and in vitro evaluation of 9-anilinoacridines active against a multidrug-resistant strain of the malaria parasite Plasmodium falciparum. J. Med. Chem. 37:1994;1486-1494.
62. Gamain B., Langsley G., Fourmaux M.N., Tousel J.P., Camus D., Dive D., Slomianny C. Molecular characterization of the glutathione peroxidase gene of the human malaria parasite Plasmodium falciparum. Mol. Biochem. Parasitol. 78:1996;237-248.
63. Gardner M.J., Williamson D.H., Wilson R.J. A circular DNA in malaria parasites encodes an RNA polymerase like that of prokaryotes and chloroplasts. Mol. Biochem. Parasitol. 44:1991;115-123.
64. Geary T.G., Jensen J.B. Effects of antibiotics on Plasmodium falciparum in vitro. Am. J. Trop. Med. Hyg. 32:1983;221-225.
65. Gero A.M., Hall S.T. Plasmodium falciparum. transport of enantiomers of nucleosides into Sendai-treated trophozoites Exp. Parasitol. 86:1997;228-231.
66. Gero A.M., Kirk K. Nutrient transport pathways in Plasmodium-infected erythrocytes. what and where are they? Parasitol. Today. 10:1994;395-399.
67. Gero A.M., O'Sullivan W.J. Purines and pyrimidines in malarial parasites. Blood Cells. 16:1990;467-484.
68. Gero A.M., Upston J.M. Altered membrane permeability. a new approach to malaria chemotherapy Parasitol. Today. 8:1992;283-286.
69. Gero A.M., Tetley K., Coombes G.H., Phillips R.S. Dihydroorotate dehydrogenase, orotate phosphoribosyltransferase and orotidine 5′-phosphate decarboxylase in Plasmodium falciparum. Trans. R. Soc. Trop. Med. Hyg. 75:1981;719-720.
70. Ginsburg H. Transport pathways in the malaria-infected erythrocyte. Their characterization and use as potential targets for chemotherapy. Biochem. Pharmacol. 48:1994;1847-1856.
71. Ginsburg H., Atamna H. The redox status of malaria-infected erythrocytes. an overview with an emphasis on unresolved problems Parasite. 1:1994;5-13.
72. Ginsburg H., Kutner S., Krugliak M., Cabantchik Z.I. Characterization of permeation pathways appearing in the host membrane of Plasmodium falciparum infected red blood cells. Mol. Biochem. Parasitol. 14:1985;313-314.
73. Ginsburg H., Atamna H., Shalmiev G., Kanaani J., Krugliak M. Resistance of glucose-6-phosphate dehydrogenase deficiency to malaria. effects of fava bean hydroxypyrimidine glucosides on Plasmodium falciparum growth in culture and on the phagocytosis of infected cells Parasitology. 113:1997;7-18.
74. Gluzman I.Y., Francis S.E., Oksman A., Smith C., Duffin K., Goldberg D.E. Order and specificity of the Plasmodium falciparum hemoglobin degradation pathway. J. Clin. Invest. 93:1994;1602-1607.
75. Goldberg D.E. Plasmodial hemoglobin degradation. an ordered pathway in a specialized organelle Infect. Agents Dis. 1:1992;207-211.
76. Goldberg D.E., Slater A.F.G., Cerami A., Henderson G.B. Hemoglobin degradation in the malaria parasite Plasmodium falciparum. an ordered process in a unique organelle Proc. Natl. Acad. Sci. USA. 87:1990;2931-2935.
77. Golenser J., Marva E., Chevion M. The survival of Plasmodium under oxidant stress. Parasitol. Today. 7:1991;142-145.
78. Gormley J.A., Howard R.J., Taraschi T.F. Trafficking of malarial proteins to the host cell cytoplasm and erythrocyte surface membrane involves multiple pathways. J. Cell Biol. 119:1992;1481-1495.
79. Gottesman M.M., Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem. 62:1993;385-427.
80. Grellier P., Rigomer D., Clavey V., Fruchart J.C., Schrevel J. Lipid traffic between high-density lipoproteins and Plasmodium falciparum-infected red blood cells. J. Cell Biol. 112:1991;267-277.
81. Gutteridge W.E., Dave D., Richards W.H.G. Conversion of dihydroorotate to orotate in parasitic protozoa. Biochim. Biophys. Acta. 582:1979;390-401.
82. Haldar K. Sphingolipid synthesis and membrane formation by Plasmodium. Trends Cell Biol. 6:1996;398-405.
83. Hassan H.F., Coombs G.H. Purine and pyrimidine metabolism in parasitic protozoa. FEMS Microbiol. Rev. 4:1988;47-83.
84. Hershko C. Control of disease by selective iron depletion. a novel therapeutic strategy utilizing iron chelators Baillieres Clin. Haematol. 7:1994;965-1000.
85. Hibbs A.R., Saul A.J. Plasmodium falciparum. highly mobile small vesicles in the malaria-infected red blood cell cytoplasm Exp. Parasitol. 79:1994;260-269.
86. Hong Y.L., Yang Y.Z., Meshnick S.R. The interaction of artemisinin with malarial hemozoin. Mol. Biochem. Parasitol. 63:1994;121-128.
87. Hudson A.T. Atovoquone - a novel broad-spectrum anti-infective drug. Parasitol. Today. 9:1993;66-68.
88. Hyde J.E. Point mutations and pyrimethamine resistance in Plasmodium falciparum. Parasitol. Today. 5:1989;252-255.
89. Hyde S.C. Structural model of ATP-binding proteins associated with cystic fibrosis, multidrug resistance and bacterial transport. Nature. 346:1990;362-365.
90. Ignatushchenko M.V., Winter R.W., Bachinger H.P., Hinrichs D.J., Riscoe M.K. Xanthones as antimalarial agents; studies of a possible mode of action. FEBS Lett. 409:1997;67-73.
91. Ittarat I., Asawamahasakda W., Meshnick S.R. The effects of antimalarials on the Plasmodium falciparum dihydroorotate dehydrogenase. Exp. Parasitol. 79:1994;50-56.
92. Ivanetich K.M., Santi D.V. Thymidylate synthase-dihydrofolate reductase in protozoa. Exp. Parasitol. 70:1990;367-371.
93. Jacobasch G., Buckwitz D., Gerth C., Thamm R. Regulation of the energy metabolism of Plasmodium berghei. Biomed. Biochim. Acta. 49:1990;S289-S294.
94. Jearnpipatkul A., Govitrapong P., Yuthavong Y., Wilairat P., Panijpan B. Binding of antimalarial drugs to hemozoin from Plasmodium berghei. Experientia. 36:1980;1063-1064.
95. Kamchonwongpaisan S., Bunyaratvej A., Wanachiwanawin W., Yuthavong Y. Susceptibility to hydrogen peroxide of Plasmodium falciparum infecting glucose-6-phosphate dehydrogenase-deficient erythrocytes. Parasitology. 99:1989;171-174.
96. Kamchonwongpaisan, S., Vanitcharoen, N. and Yuthavong, Y. (1992) The mechanism of antimalarial action of artemisinin. In: Lipid-Soluble Antioxidants: Biochemistry and Clinical Applications, pp. 363-372, Ong, A. S. H. and Packer, L. (eds.) Berkhauser Verlag, Basel.
97. Kamchonwongpaisan S., Samoff E., Meshnick S.R. Identification of hemoglobin degradation products in Plasmodium falciparum. Mol. Biochem. Parasitol. 86:1997;179-186.
98. Kiatfuengfoo R., Suthipongchai T., Prapunwattana P., Yuthavong Y. Mitochondria as the site of action of tetracycline on Plasmodium falciparum. Mol. Biochem. Parasitol. 34:1989;109-116.
99. Kirk K., Horner H.A., Elford B.C., Ellory J.C., Newbold C.I. Transport of diverse substrates into malaria-infected erythrocytes via a pathway showing functional characteristics of a chloride channel. J. Biol. Chem. 269:1994;3339-3347.
100. Köler S., Delwiche C.F., Denny P.W., Tilney L.G., Webster P., Wilson R.J.M., Palmer J.D., Roos D.S. A plastid of probable green algal origin in apicomplexan parasites. Science. 275:1997;1485-1489.
101. Krauth-Siegel R.L., Muller J.G., Lottspeich F., Schirmer R.H. Glutathione reductase and glutamate dehydrogenase of Plasmodium falciparum, the causative agent of tropical malaria. Eur. J. Biochem. 235:1996;345-350.
102. Krishna S., Suparanond W., Pukrittayakamee S., Ter Kuile F., Ruprah M., White N.J. The disposition and effects of two doses of dichloroacetate in adults with severe falciparum malaria. Br. J. Clin. Pharmacol. 41:1996;29-34.
103. Krungkrai J. Malarial dihydroorotate dehydrogenase mediates superoxide radical production. Biochem. Int. 24:1991;833-839.
104. Krungkrai J. Purification, characterization and localization of mitochondrial dihydroorotate dehydrogenase in Plasmodium falciparum, human malaria parasite. Biochim. Biophys. Acta. 1243:1995;351-360.
105. Krungkrai J., Webster H.K., Yuthavong Y. De novo and salvage biosynthesis of pteroyl pentaglutamates in the human malaria parasite, Plasmodium falciparum. Mol. Biochem. Parasitol. 32:1989;25-38.
106. Krungkrai J., Cerami A., Henderson G.B. Pyrimidine biosynthesis in parasitic protozoa. purification of a monofunctional dihydroorotatase from Plasmodium berghei and Crithidia fasciculata Biochemistry. 29:1990;6270-6275.
107. Krungkrai J., Krungkrai S.R., Phakanont K. Antimalarial activity of orotate analogs that inhibit dihydroorotase and dihydrorotate dehydrogenase. Biochem. Pharmacol. 17:1992;1295-1301.
108. Krungkrai J., Krungkrai S.R., Suraveratum N., Prapunwattana P. Mitochondrial ubiquinol-cytochrome C reductase and cytochrome C oxidase. chemotherapeutic targets in malarial parasites Biochem. Mol. Biol. Int. 42:1997;1007-1014.
109. Krungkrai S.R., Yuthavong Y. The antimalarial action on Plasmodium falciparum of qinghaosu and artesunate in combination with agents which modulate oxidant stress. Trans. R. Soc. Trop. Med. Hyg. 81:1987;710-714.
110. Kyle D.E., Milhous W.K., Rossan R.N. Reversal of Plasmodium falciparum resistance to chloroquine in Panamanian Aotus monkey. Am. J. Trop. Med. Hyg. 48:1993;126-133.
111. Langreth S.G., Jensen J.B., Reese R.T., Trager W. Fine structure of human malaria in vitro. J. Protozool. 25:1978;443-452.
112. Lang-Unnasch N. Purification and properties of Plasmodium falciparum malate dehydrogenase. Mol. Biochem. Parasitol. 50:1992;17-25.
113. Lauer S.A., Ghori N., Haldar K. Sphingolipid synthesis as a target for chemotherapy against malaria parasites. Proc. Natl. Acad. Sci. USA. 92:1995;9181-9185.
114. Lauer S.A., Rathod P.K., Ghori N., Haldar K. A membrane network for nutrient import in red cells infected with the malaria parasite. Science. 276:1997;1122-1125.
115. Lautier D., Canitrot Y., Deeley R.G., Cole S.P. Multidrug resistance mediated by multidrug resistance protein (MRP) gene. Biochem. Pharmacol. 52:1996;967-977.
116. Levitzki A. Targeting signal transduction for disease therapy. Curr. Opin. Cell Biol. 8:1996;239-244.
117. Luzzatto L. About hemoglobins, G6PD and parasites in red cells. Experientia. 51:1995;206-208.
118. Lytton S.D., Mester B., Libman J., Shanzer A., Cabantchik Z.I. Mode of action of iron(III) chelators as antimalarials. II. Evidence for differential effects on parasite iron-dependent nucleic acid synthesis Blood. 84:1994;910-915.
119. Makler M.T., Ries J.M., Williams J.A., Bancroft J.E., Piper R.C., Gibbins B.L., Hinrichs D.J. Parasite lactate dehydrogenase as an assay for Plasmodium falciparum drug sensitivity. Am. J. Trop. Med. Hyg. 48:1993;739-741.
120. Manandhar M.S.P., Van Dyke K. Detailed purine salvage metabolism in and outside the free malaria parasite. Exp. Parasitol. 37:1975;138-146.
121. McConkey G.A., Rogers M.J., McCutchan T.F. Inhibition of Plasmodium falciparum protein synthesis. Targeting the plastid-like organelle with thiostrepton. J. Biol. Chem. 272:1997;2046-2049.
122. McFadden G.I., Reith M.E., Mulholland J., Lang-Unnash N. Plastid in human parasites. Nature. 381:1996;482.
123. Meshnick S.R. The mode of action of antimalarial endoperoxides. Trans. R. Soc. Trop. Med. Hyg. 88(Suppl. 1):1994;S31-S32.
124. Meshnick S.R., Yang Y.Z., Lima V., Kuypers F., Kamchonwongpaisan S., Yuthavong Y. Iron-dependent free radical generation from the antimalarial agent artemisinin (qinghaosu). Antimicrob. Agents Chemother. 37:1993;1108-1114.
125. Meshnick S.R., Taylor T., Kamchonwongpaisan S. Artemisinin and the antimalarial endoperoxides. from herbal remedy to targeted chemotherapy Microbiol. Rev. 60:1996;301-315.
126. Müller S., Becker K., Bergmann B., Schirmer R.H., Walter R.D. Plasmodium falciparum glutathione reductase exhibits sequence similarities with the human host enzyme in the core structure but differs at the ligand binding site. Mol. Biochem. Parasitol. 74:1995;11-18.
127. Murphy A.D., Doeller J.E., Hearn B., Lang-Unnasch N. Plasmodium falciparum. Cyanide-resistant oxygen consumption Exp. Parasitol. 87:1997;112-120.
128. Oduola A.M., Omitowoju G.O., Gerena L., Kyle D.E., Milhous W.K., Sowunmi A., Salako L.A. Reversal of mefloquine resistance with penfluridol in isolates of Plasmodium falciparum from south-west Nigeria. Trans. R. Soc. Trop. Med. Hyg. 87:1993;81-83.
129. Olliaro P. How Plasmodium secures nutrients. new targets for drugs? Parasitol. Today. 10:1994;4-5.
130. Olliaro P.L., Goldberg D.E. The Plasmodium digestive vacuole. metabolic headquarters and choice drug target Parasitol. Today. 11:1995;294-297.
131. Olliaro P., Wirth D. New targets for antimalarial drug discovery. J. Pharm. Pharmacol. 49(Suppl. 2):1996;29-33.
132. Olliaro P.L., Gottlieb M.L., Wirth D.F. Plasmodium falciparum proteinases. targeted drug development Parasitol. Today. 12:1996;413-414.
133. Orjih A.U., Ryerse J.S., Fitch C.D. Hemoglobin catabolism and the killing of intraerythrocytic Plasmodium falciparum by chloroquine. Experientia. 50:1994;34-39.
134. Ostresh J.M., Husar G.M., Blondelle S.E., Dörner B., Weber P.A., Houghten R.A. "Libraries from libraries" chemical transformation of combinatorial libraries to extend the range and repertoire of chemical diversity Proc. Natl. Acad. Sci. USA. 91:1994;11138-11142.
135. Paitayatat S., Tarnchompoo B., Thebtaranonth Y., Yuthavong Y. Correlation of antimalarial activity of artemisinin derivatives with binding affinity with ferroprotoporphyrin IX. J. Med. Chem. 40:1997;633-638.
136. Pandey A.V., Tekwani B.L. Formation of haemozoin/b-haematin under physiological conditions is not spontaneous. FEBS Lett. 393:1996;189-192.
137. Paul R.E.L., Packer M.J., Wlamsley M., Lagog M., Ranford-Cartwright L.C., Paru R., Day K.N. Mating patterns in malaria parasites populations of Papua New Guinea. Science. 269:1995;1709-1711.
138. Peel S.A., Bright P., Yount B., Handy J., Baric R.S. A strong association between mefloquine and halofantrine resistance and amplification, overexpression, and mutation in the P-glycoprotein gene homolog (pfmdr) of Plasmodium falciparum in vitro. Am. J. Trop. Med. Hyg. 51:1994;648-658.
139. Peterson D.S., Milhous W.K., Wellems T.E. Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria. Proc. Natl. Acad. Sci. USA. 87:1990;3018-3022.
140. Petmitr S., Krungkrai J. Mitochondrial cytochrome b gene in two developmental stages of human malarial parasite Plasmodium falciparum. Southeast Asian J. Trop. Med. Public Health. 26:1995;600-605.
141. Pouvelle B., Spuegel R., Hsiao L., Howard R.J., Morris R.L., Thomas A.P., Taraschi T.F. Direct access to serum macromolecules by intraerythrocytic malaria parasites. Nature. 353:1991;73-75.
142. Pouvelle B., Farley P.J., Long C.A., Taraschi T.F. Taxol arrests the development of blood stage Plasmodium falciparum in vitro and Plasmodium chabaudi adami in malaria-infected mice. J. Clin. Invest. 94:1994;413-417.
143. Pradines B., Ramiandrasoa F., Basco L.K., Bricard L., Kunesch G., Le Bras J. In vitro activities of novel catecholate siderophores against Plasmodium falciparum. Antimicrob. Agents Chemother. 40:1996;2094-2098.
144. Prapunwattana P., O'Sullivan W.J., Yuthavong Y. Depression of Plasmodium falciparum dihydroorotate dehydrogenase activity in in vitro culture by tetracycline. Mol. Biochem. Parasitol. 27:1988;119-124.
145. Prapunwattana P., Sirawaraporn W., Yuthavong Y., Santi D.V. Chemical synthesis of the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene. Mol. Biochem. Parasitol. 83:1996;93-106.
146. Preiser P.R., Wilson R.J., Moore P.W., McCready S., Hajibagheri M.A., Blight K.J., Strath M., Williamson D.H. Recombination associated with replication of malarial mitochondrial DNA. EMBO J. 15:1996;684-693.
147. Ranz A., Meshnick S. Plasmodium falciparum. inhibitor sensitivity of the endogenous superoxide dismutase Exp. Parasitol. 69:1989;125-128.
148. Rathod P.K., Reyes P. Orotidylate-metabolizing enzymes of the human malarial parasite, Plasmodium falciparum, differ from host cell enzymes. J. Biol. Chem. 258:1983;2852-2855.
149. Rathod P.K., Leffers N.P., Young R.D. Molecular targets of 5-fluoroorotate in the human malaria parasite, Plasmodium falciparum. Antimicrob. Agents Chemother. 36:1992;704-711.
150. Raviv Y., Pollard H.B., Bruggemann E.P., Pastan I., Gottesman M.M. Photosensitized labeling of a functional multidrug transporter in living drug-resistant tumor cells. J. Biol. Chem. 265:1990;3975-3980.
151. Raynes K., Foley M., Tilley L., Deady L.W. Novel bisquinoline antimalarials. Synthesis, antimalarial activity, and inhibition of haem polymerisation. Biochem. Pharmacol. 52:1996;551-559.
152. Ridley R. Haemozoin formation in malaria parasites. is there a haem polymerase? Trends Microbiol. 4:1996;253-254.
153. Riordan J.E., Deuchars K., Kartner N., Alon N., Trent J., Ling V. Amplification of P-glycoprotein genes in multidrug resistant mammalian cell lines. Nature. 316:1985;817-819.
154. Riou J.F., Gabillot M., Philippe M., Schrevel J., Riou G. Purification and characterization of Plasmodium berghei DNA topoisomerases I and II. drug action, inhibition of decatenation and relaxation, and stimulation of DNA cleavage Biochemistry. 25:1986;1471-1479.
155. Roepe P.D. The role of MDR protein in altered drug translocation across tumor cell membranes. Biochim. Biophys. Acta. 1241:1995;385-406.
156. Rosenthal P.J., Nelson R.G. Isolation and characterization of a cysteine proteinase gene of Plasmodium falciparum. Mol. Biochem. Parasitol. 51:1992;143-152.
157. Rosenthal P.J., McKerrow J.H., Aikawa M., Nagasawa H., Leech J.H.D. A malarial cysteine proteinase is necessary for hemoglobin degradation by Plasmodium falciparum. J. Clin. Invest. 82:1988;1560-1566.
158. Rosenthal P.J., Wollish W.S., Palmer J.T., Rasnick D. Antimalarial effects of peptide inhibitors of a Plasmodium falciparum cysteine proteinase. J. Clin. Invest. 88:1991;1467-1472.
159. Rubin H., Salem J.S., Li L.S., Yang F.D., Mama S., Wang Z.M., Fisher A., Hamann C.S., Cooperman B.S. Cloning, sequence determination, and regulation of the ribonucleotide reductase subunits from Plasmodium falciparum. a target for antimalarial therapy Proc. Natl. Acad. Sci. USA. 90:1993;9280-9284.
160. Ruwende C., Khoo S.C., Snow R.W., Yates S.N., Kwiatkowski D., Gupta S., Warn P., Allsopp C.E., Gilbert S.C., Peschu N., Newbold C.I., Greenwood B.M., Marsh K., Hill A.V.S. Natural selection of hemi- and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria. Nature. 376:1995;246-249.
161. Sano G., Morimatsu K., Horii T. Purification and characterization of dihydrofolate reductase of Plasmodium falciparum expressed by a synthetic gene in Escherichia coli. Mol. Biochem. Parasitol. 63:1994;265-273.
162. Scheibel L., Sherman I.W. Purine transport and the salvage pathway. Wernsdorfer W.H., McGregor I.A. Malaria. Principles and Practice of Malariology, Vol. I:1988;237-239 Churchill Livingstone, Edinburgh.
163. Schirmer R.H., Müller J.G., Krauth-Siegel R.L. Disulfide-reductase inhibitors as chemotherapeutic agents. the design of drugs for trypanosomiasis and malaria Angew. Chem. Int. Ed. Engl. 34:1995;141-154.
164. Schrevel J., Sinou V., Grellier P., Frappier F., Guenard D., Potier P. Interactions between docetaxel (Taxotere) and Plasmodium falciparum-infected erythrocytes. Proc. Natl. Acad. Sci. USA. 91:1994;8472-8476.
165. Sessions R.B., Dewar V., Clarke A.R., Holbrook J.J. A model of Plasmodium falciparum lactate dehydrogenase and its implications for the design of improved antimalarials and the enhanced detection of parasitaemia. Protein Eng. 10:1997;301-306.
166. Seymour K.K., Lyons S.D., Phillips L., Rieckmann K.H., Christopherson R.I. Cytotoxic effects of inhibitors of de novo pyrimidine biosynthesis upon Plasmodium falciparum. Biochemistry. 33:1994;5268-5274.
167. Sherman I.W. Biochemistry of Plasmodium (malarial parasite). Microbiol. Rev. 43:1979;453-495.
168. Sirawaraporn W., Yuthavong Y. Kinetic and molecular properties of dihydrofolate reductase from pyrimethamine-sensitive and pyrimethamine-resistant Plasmodium chabaudi. Mol. Biochem. Parasitol. 10:1984;355-367.
169. Sirawaraporn W., Sirawaraporn R., Cowman A.F., Yuthavong Y., Santi D.V. Heterologous expression of active thymidylate synthase-dihydrofolate reductase from Plasmodium falciparum. Biochemistry. 29:1990;10779-10785.
170. Sirawaraporn W., Prapunwattana P., Yuthavong Y., Santi D.V. The dihydrofolate reductase domain of Plasmodium falciparum thymidylate synthase-dihydrofolate reductase. gene synthesis, expression, and anti-folate resistant mutants J. Biol. Chem. 268:1993;21637-21644.
171. Sirawaraporn W., Sathitkul T., Sirawaraporn R., Yuthavong Y., Santi D.V. Antifolate-resistant mutants of Plasmodium falciparum dihydrofolate reductase. Proc. Natl. Acad. Sci. USA. 94:1997;1124-1129. a.
172. Sirawaraporn W., Yongkiettrakul S., Sirawaraporn R., Yuthavong Y., Santi D.V. Plasmodium falciparum. asparagine mutant at residue 108 of dihydrofolate reductase is an optimal antifolate-resistant single mutant Exp. Parasitol. 87:1997;245-252. b.
173. Slater A.F. Malaria pigment. Exp. Parasitol. 74:1992;362-365.
174. Slater A.F.G. Chloroquine. mechanism of drug action and resistance in Plasmodium falciparum Pharmacol. Ther. 57:1993;203-235.
175. Slater A.F.G., Cerami A. Inhibition by chloroquine of a novel haem polymerase enzyme activity in malaria trophozoite. Nature. 355:1992;167-169.
176. Slater A.F., Swiggard W.J., Orton B.R., Flitter W.D., Goldberg D.E., Cerami A., Henderson G.B. An iron carboxylate bond links the heme units of malaria pigment. Proc. Natl. Acad. Sci. USA. 88:1991;325-329.
177. Srivastava I.K., Rottenberg H., Vaidya A.B. Atovaquone, a broad spectrum antiparasitic drug, collapses mitochondrial membrane potential in a malarial parasite. J. Biol. Chem. 272:1997;3961-3966.
178. Strath M., Scott-Finnigan T., Gardner M., Williamson D.H., Wilson R.J.M. Antimalarial activity of rifampicin in vitro and in rodent malaria. Trans. R. Soc. Trop. Med. Hyg. 87:1993;211-216.
179. Sullivan D., Gluzman I., Goldberg D. Plasmodium hemozoin formation mediated by histidine-rich proteins. Science. 271:1996;219-222.
180. Tarlov A.R.G., Brewer G.J., Carson P.E., Alving A.S. Primaquine sensitivity. Glucose 6-phosphate dehydrogenase deficiency. an inborn error of metabolism of medical and biological significance Arch. Int. Med. 109:1962;209-234.
181. Thaithong S., Chan S.W., Songsomboon S., Wilairat P., Seesod N., Sueblinwong T., Goman M., Ridley R., Beale G. Pyrimethamine resistant mutations in Plasmodium falciparum. Mol. Biochem. Parasitol. 52:1992;149-157.
182. Toyoda T., Brobey R.K.B., Sano G., Horii T. Lead discovery of inhibitors of dihydrofolate reductase domain of Plasmodium falciparum dihydrofolate reductase-thymidylate synthase. Biochem. Biophys. Res. Commun. 235:1997;515-519.
183. Trager, W. and Jensen, J. B. (1976) Human malaria parasites in continuous culture. Science 1993: 673-675.
184. Triglia T., Cowman A.F. Primary structure and expression of the dihydropteroate synthase gene of Plasmodium falciparum. Proc. Natl. Acad. Sci. USA. 91:1994;7149-7153.
185. Triglia T., Menting J.G.T., Wilson C., Cowman A.F. Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum. Proc. Natl. Acad. Sci. USA. 994:1997;13944-13949.
186. Upston J.M., Gero A. Parasite-induced permeation of nucleosides in Plasmodium falciparum malaria. Biochim. Biophys. Acta. 1236:1995;249-258.
187. Vaidya A.B., Lashgari M.S., Pologe L.G., Morrisey J. Structural features of Plasmodium cytochrome b that may underlie susceptibility to 8-aminoquinolines and hydroxynaphthoquinones. Mol. Biochem. Parasitol. 58:1993;33-42.
188. Vance J.E. Phospholipid synthesis in a membrane fraction associated with mitochondria. J. Biol. Chem. 265:1990;7248-7256.
189. Vander Jagt D.L., Hunsaker L.A., Kibirige M., Campos N.M. NADPH production by the malarial parasite Plasmodium falciparum. Blood. 74:1989;471-474.
190. Vasanthakumar G., Davis R.L., Sullivan M.A., Donahue J.P. Cloning and expression of a hypoxanthine-guanine phosphoribosil transferase cDNA from Plasmodium falciparum in E. coli. Gene. 91:1990;63-69.
191. Vasanthakumar G., van Ginkel S.S., Parish G. Isolation and sequencing of a cDNA encoding the hypoxanthine-guanine phosphoribosyltransferase from Toxoplasma gondii. Gene. 147:1994;153-154.
192. Vennerstrom J., Eaton J. Oxidants, oxidant drugs, and malaria. J. Med. Chem. 31:1988;1269-1277.
193. Vial H. Recent developments and rationale towards new strategies for malarial chemotherapy. Parasite. 3:1996;3-23.
194. Vial H., Ancelin M.L. Malaria lipids, an overview. Avila J.L., Harris J.R. Subcellular Biochemistry. 1992;259-306 Plenum Press, New York.
195. Volkman S.K., Wilson C.M., Wirth D.F. Stage-specific transcripts of Plasmodium falciparum pfmdr1 gene. Mol. Biochem. Parasitol. 57:1993;203-212.
196. Wang P., Lee C.S., Bayoumi R., Djimde A., Doumbo O., Swedberg G., Dao L.D., Mshinda H., Tanner M., Watkins W.M., Sims P.F., Hyde J.E. Resistance to antifolates in Plasmodium falciparum, monitored by sequence analysis of dihydropteroate synthetase and dihydrofolate reductase alleles in large number of field samples of diverse origins. Mol. Biochem. Parasitol. 8:1997;161-177.
197. Wernsdorfer W., McGregor I. Malaria. Principles and Practice of Malariology, Vols. 1 and 2. 1988;Churchill Livingstone, Edinburgh.
198. Westling J., Yowell C.A., Majer P., Erickson J.W., Dame J.B., Dunn B.M. Plasmodium falciparum, P. vivax, and P. malariae. a comparison of the active site properties of plasmepsins cloned and expressed from three different species of the malaria parasite Exp. Parasitol. 87:1997;185-193.
199. White J.H., Kilbey B.J., de Vries E., Goman M., Alano P., Cheesman S., McAleese S., Ridley R.G. The gene encoding DNA polymerase alpha from Plasmodium falciparum. Nucl. Acids Res. 21:1993;3643-3646.
200. Wilson C.M., Volkman S.K., Thaithong S., Martin R.K., Kyle D.S., Milhous W.K., Wirth D.F. Amplification of pfmdr1 associated with mefloquine and halofantrine resistance in Plasmodium falciparum in Thailand. Mol. Biochem. Parasitol. 57:1993;151-160.
201. Wilson R.J., Williamson D.H. Extrachromosomal DNA in the Apicomplexa. Microbiol. Mol. Biol. Rev. 61:1997;1-16.
202. Wilson R.J.M., Gardner M.J., Feagin J.E., Williamson D.H. Have malaria parasites three genomes? Parasitol. Today. 7:1991;134-136.
203. Wilson R.J.M., Denny P.W., Preiser P.R., Rangachari K., Roberts K., Roy Q., Whyte A., Strath M., Moore D.J., Moore P.W., Williamson D.H. Complete gene map of the plastid-like DNA of the malaria parasite Plasmodium falciparum. J. Mol. Biol. 261:1996;155-172.
204. Yang Y.Z., Little B., Meshnick S.R. Alkylation of proteins by artemisinin. Effects of heme, pH, and drug structure. Biochem. Pharmacol. 48:1993;569-573.
205. Yeo H.J., Sri Widada J., Mercereau-Puijalon O., Vial H.J. Molecular cloning of CTP. phosphocholine cytidylyltransferase from Plasmodium falciparum Eur. J. Biochem. 233:1995;62-72.
206. Zhang Y., Konig I., Schirmer R.H. Glutathione-deficient erythrocytes as host cells of malaria parasites. Biochem. Pharmacol. 37:1988;861-865.
207. Zhao Y., Kappes B., Franklin M. Gene structure and expression of an unusual protein kinase from Plasmodium falciparum homologous at the carboxyl terminus with the EF hand calcium-binding proteins. J. Biol. Chem. 268:1993;4347-4354.
208. Zolg J.W., Plitt J.R., Chen G.X., Palmer S. Point mutations in the dihydrofolate reductase-thymidylate synthase gene as the molecular basis for pyrimethamine resistance in Plasmodium falciparum. Mol. Biochem. Parasitol. 36:1989;253-262.